Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Fragile X Mental Retardation Protein (FMRP) controls diacylglycerol kinase activity in neurons.

Tabet R, Moutin E, Becker JA, Heintz D, Fouillen L, Flatter E, Krężel W, Alunni V, Koebel P, Dembélé D, Tassone F, Bardoni B, Mandel JL, Vitale N, Muller D, Le Merrer J, Moine H.

Proc Natl Acad Sci U S A. 2016 Jun 28;113(26):E3619-28. doi: 10.1073/pnas.1522631113. Epub 2016 May 27.

2.

G-quadruplex RNA structure as a signal for neurite mRNA targeting.

Subramanian M, Rage F, Tabet R, Flatter E, Mandel JL, Moine H.

EMBO Rep. 2011 Jul 1;12(7):697-704. doi: 10.1038/embor.2011.76.

3.

Cells lacking the fragile X mental retardation protein (FMRP) have normal RISC activity but exhibit altered stress granule assembly.

Didiot MC, Subramanian M, Flatter E, Mandel JL, Moine H.

Mol Biol Cell. 2009 Jan;20(1):428-37. doi: 10.1091/mbc.E08-07-0737. Epub 2008 Nov 12.

4.

Induction of somatic hypermutation in immunoglobulin genes is dependent on DNA polymerase iota.

Faili A, Aoufouchi S, Flatter E, Guéranger Q, Reynaud CA, Weill JC.

Nature. 2002 Oct 31;419(6910):944-7.

PMID:
12410315
5.

Ig gene hypermutation: a mechanism is due.

Weill JC, Bertocci B, Faili A, Aoufouchi S, Frey S, De Smet A, Storck S, Dahan A, Delbos F, Weller S, Flatter E, Reynaud CA.

Adv Immunol. 2002;80:183-202. Review. No abstract available.

PMID:
12078481
6.

Cutting edge: DNA polymerases mu and lambda are dispensable for Ig gene hypermutation.

Bertocci B, De Smet A, Flatter E, Dahan A, Bories JC, Landreau C, Weill JC, Reynaud CA.

J Immunol. 2002 Apr 15;168(8):3702-6.

7.

Transcription, beta-like DNA polymerases and hypermutation.

Reynaud CA, Frey S, Aoufouchi S, Faili A, Bertocci B, Dahan A, Flatter E, Delbos F, Storck S, Zober C, Weill JC.

Philos Trans R Soc Lond B Biol Sci. 2001 Jan 29;356(1405):91-7. Review.

8.

Two novel human and mouse DNA polymerases of the polX family.

Aoufouchi S, Flatter E, Dahan A, Faili A, Bertocci B, Storck S, Delbos F, Cocea L, Gupta N, Weill JC, Reynaud CA.

Nucleic Acids Res. 2000 Sep 15;28(18):3684-93.

9.

A dual approach in the study of poly (ADP-ribose) polymerase: in vitro random mutagenesis and generation of deficient mice.

Trucco C, Rolli V, Oliver FJ, Flatter E, Masson M, Dantzer F, Niedergang C, Dutrillaux B, Ménissier-de Murcia J, de Murcia G.

Mol Cell Biochem. 1999 Mar;193(1-2):53-60.

PMID:
10331638
10.

Involvement of poly(ADP-ribose) polymerase in base excision repair.

Dantzer F, Schreiber V, Niedergang C, Trucco C, Flatter E, De La Rubia G, Oliver J, Rolli V, Ménissier-de Murcia J, de Murcia G.

Biochimie. 1999 Jan-Feb;81(1-2):69-75. Review.

PMID:
10214912
11.

Role of nitric oxide in pancreatic tumour growth: in vivo and in vitro studies.

Hajri A, Metzger E, Vallat F, Coffy S, Flatter E, Evrard S, Marescaux J, Aprahamian M.

Br J Cancer. 1998 Oct;78(7):841-9.

12.

Mutations in the amino-terminal domain of the human poly(ADP-ribose) polymerase that affect its catalytic activity but not its DNA binding capacity.

Trucco C, Flatter E, Fribourg S, de Murcia G, Ménissier-de Murcia J.

FEBS Lett. 1996 Dec 16;399(3):313-6.

Supplemental Content

Loading ...
Support Center